CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

US Open: Wall Street opens higher - important week ahead!

15:30 28 August 2023
  • Wall Street opened slightly higher ahead of labor market data later this week
  • 3M has agreed to pay more to resolve lawsuits
  • The Jackson Hole event brought no expected changes

Wall Street opened slightly higher today, marking the start of an intense week. While no significant macro data is scheduled for today, investors will be served with several key labor data indicators in the coming days. Currently, the SP500 is up by 0.60%, and the Nasdaq 100 is increasing by 0.82%. 

Over the weekend, the Jackson Hole symposium ended. Contrary to the expectations of many investors for a change in the global tightening policy, the conference was even perceived by some experts to set the stage for future interest rate hikes. At Jackson Hole, Federal Reserve Chair Jerome Powell conveyed a cautious approach to further interest-rate hikes, signaling a high bar for more tightening. Some interpreted Powell's comments as hawkish, hinting at potential hikes, while others saw them as fundamentally optimistic yet cautious. A number of regional Fed officials noted the favorable direction of inflation, suggesting that increasing yields might stabilize the economy. Despite this cautious optimism, derivative market traders are leaning toward a rate hike in November. After the Jackson Hole event, the focus will shift to the forthcoming August employment report. Powell emphasized that any signs of a robust labor market might prompt a monetary policy adjustment.

Start investing today or test a free demo

Open account Try demo Download mobile app Download mobile app

The US500 index is currently trading at 4440, marking an increase of 0.50% for the day. Notably, the price has twice tested the 4378 mark, reinforcing it as a strong support zone. Following this test, the index has rebounded today and is now on track to approach the 4500 level, which is identified as the next resistance zone. The forthcoming macroeconomic data to be released by the end of the week will likely influence the US500 next moves. Specifically, if the labor market appears to be strong again, there's a potential for the index to retract back to the 4378 point level.

 

Company news:

  • 3M (MMM.US) stock rose 4.7% after agreeing to pay over $5.5 billion to settle more than 300,000 lawsuits alleging it provided the US military with faulty combat earplugs, according to Bloomberg News. Analysts believe this move could lift the stock's lingering uncertainties. Citi's Andrew Kaplowitz notes the settlement is smaller than anticipated and might help 3M shift away from the persistent legal challenges affecting its valuation. RBC's Deane Dray perceives the settlement as progress in 3M's ongoing legal battles, attributing the stock's positive response to the lower-than-expected settlement and potential reduction in legal pressures. However, Bloomberg Intelligence warns that this agreement doesn't rule out further potential downgrades for 3M's ratings.

Source: xStation 5

  • Boston Scientific Corp. (BSX.US) shares are rising 5.7% after announcing that a study for its atrial fibrillation treatment met its primary efficacy and safety endpoints. The Farapulse Pulsed Field Ablation (PFA) System achieved a single-procedure, off-drug treatment success of 73.3% over 12 months, compared to 71.3% in the thermal arm of the study. Analyst feedback was largely positive, emphasizing the robust data, predicting U.S. approval for Farapulse, and highlighting its potential for market share gains. Many anticipate the product's approval in 2024, with some noting its potential to drive significant revenue growth and share gains for Boston Scientific's Electrophysiology segment.

  • Xpeng Inc. (XPEV.US) announced the agreement to acquire Didi Global Inc.’s smart-car development division for an all-stock deal valued at HK$5.84 billion ($744 million). This acquisition not only helps Xpeng eliminate a potential rival in the electric-vehicle sector but also equips them with a technologically advanced ally. Post-acquisition, Didi will hold a 3.25% stake in Xpeng. Furthermore, Xpeng has plans to introduce a new EV brand by 2024 in collaboration with Didi, aiming for the broader market with an approximate price of $20,000.

Source: xStation 5

  • CrowdStrike (CRWD.US) falls 2.2% as Morgan Stanley downgrades the software company to equal-weight from overweight ahead of 2Q earnings, citing likelihood of cut to consensus estimates and saying riskreward appears more balanced after strong YTD rally

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Back
Xtb logo

Join over 1 Million investors from around the world

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
Description
SERVERID
userBranchSymbol cc 2 March 2024
adobe_unique_id cc 1 March 2025
test_cookie cc 1 March 2024
SESSID cc 9 September 2022
__hssc cc 1 March 2024
__cf_bm cc 1 March 2024
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
Description
_gid cc 9 September 2022
_gat_UA-22576382-1 cc 8 September 2022
_gat_UA-121192761-1 cc 8 September 2022
_ga_CBPL72L2EC cc 1 March 2026
_ga cc 1 March 2026
AnalyticsSyncHistory cc 8 October 2022
af_id cc 31 March 2025
afUserId cc 1 March 2026
af_id cc 1 March 2026
AF_SYNC cc 8 March 2024
__hstc cc 28 August 2024
__hssrc

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
Description
MUID cc 26 March 2025
_omappvp cc 11 February 2035
_omappvs cc 1 March 2024
_uetsid cc 2 March 2024
_uetvid cc 26 March 2025
_fbp cc 30 May 2024
fr cc 7 December 2022
muc_ads cc 7 September 2024
lang
_ttp cc 26 March 2025
_tt_enable_cookie cc 26 March 2025
_ttp cc 26 March 2025
hubspotutk cc 28 August 2024

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name
Description
personalization_id cc 7 September 2024
UserMatchHistory cc 8 October 2022
bcookie cc 8 September 2023
lidc cc 9 September 2022
lang
bscookie cc 8 September 2023
li_gc cc 7 March 2023

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence
Language